Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/50675
Tipo de documento
ArtigoDireito Autoral
Acesso restrito
Coleções
Metadata
Mostrar registro completo
MALARIA-INDUCED NLRP12/NLRP3-DEPENDENT CASPASE-1 ACTIVATION MEDIATES INFLAMMATION AND HYPERSENSITIVITY TO BACTERIAL SUPERINFECTION
Autor(es)
Silva, Marco Antônio Ataíde
Andrade, Warrison Athanásio Coelho de
Zamboni, Dario Simões
Wang, Donghai
Souza, Maria do Carmo
Franklin, Bernardo Simões
Elian, Samir
Martins, Flaviano dos Santos
Pereira, Dhélio Batista
Reed, George
Fitzgerald, Katherine A.
Golenbock, Douglas Taylor
Gazzinelli, Ricardo Tostes
Andrade, Warrison Athanásio Coelho de
Zamboni, Dario Simões
Wang, Donghai
Souza, Maria do Carmo
Franklin, Bernardo Simões
Elian, Samir
Martins, Flaviano dos Santos
Pereira, Dhélio Batista
Reed, George
Fitzgerald, Katherine A.
Golenbock, Douglas Taylor
Gazzinelli, Ricardo Tostes
Afiliação
Fundação Oswaldo Cruz.Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil/Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquímica e Imunologia. Belo Horizonte, MG, Brazil/Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Fundação Oswaldo Cruz.Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil/Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquímica e Imunologia. Belo Horizonte, MG, Brazil/Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Ribeirão Preto, SP, Brazil
Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Ribeirão Preto, SP, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Microbiologia. Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Microbiologia. Belo Horizonte, MG, Brazil
Centro de Pesquisas em Medicina Tropical. Porto Velho, RO, Brazil
Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Fundação Oswaldo Cruz.Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil/Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Fundação Oswaldo Cruz.Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil/Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquímica e Imunologia. Belo Horizonte, MG, Brazil/Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Fundação Oswaldo Cruz.Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil/Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquímica e Imunologia. Belo Horizonte, MG, Brazil/Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Ribeirão Preto, SP, Brazil
Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Ribeirão Preto, SP, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Microbiologia. Belo Horizonte, MG, Brazil
Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Microbiologia. Belo Horizonte, MG, Brazil
Centro de Pesquisas em Medicina Tropical. Porto Velho, RO, Brazil
Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Fundação Oswaldo Cruz.Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil/Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Fundação Oswaldo Cruz.Centro de Pesquisas René Rachou. Laboratório de Imunopatologia Belo Horizonte, MG, Brazil/Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquímica e Imunologia. Belo Horizonte, MG, Brazil/Division of Infectious Diseases and Immunology. University of Massachusetts Medical School. Worcester, Massachusetts, United States of America
Resumo em Inglês
Cyclic paroxysm and high fever are hallmarks of malaria and are associated with high levels of pyrogenic cytokines, including IL-1. In this report, we describe a signature for the expression of inflammasome-related genes and caspase-1 activation in malaria. Indeed, when we infected mice, Plasmodium infection was sufficient to promote MyD88-mediated caspase-1 activation, dependent on IFN--priming and the expression of inflammasome components ASC, P2X7R, NLRP3 and/or NLRP12. Pro-IL-1 expression required a second stimulation with LPS and was also dependent on IFN--priming and functional TNFR1. As a consequence of Plasmodium-induced caspase-1 activation, mice produced extremely high levels of IL-1 upon a second microbial stimulus, and became hypersensitive to septic shock. Therapeutic intervention with IL-1 receptor antagonist prevented bacterial-induced lethality in rodents. Similar to mice, we observed a significantly increased frequency of circulating CD14(+)CD16(-)Caspase-1(+) and CD14(dim)CD16(+)Caspase-1(+) monocytes in peripheral blood mononuclear cells from febrile malaria patients. These cells readily produced large amounts of IL-1 after stimulation with LPS. Furthermore, we observed the presence of inflammasome complexes in monocytes from malaria patients containing either NLRP3 or NLRP12 pyroptosomes. We conclude that NLRP12/NLRP3-dependent activation of caspase-1 is likely to be a key event in mediating systemic production of IL-1 and hypersensitivity to secondary bacterial infection during malaria. Author Summary Together Plasmodium falciparum and P. vivax infect approximately 250 million individuals, reaping life of near one million children every year. Extensive research on malaria pathogenesis has funneled into the consensus that the clinical manifestations are often a consequence of the systemic inflammation. Importantly, secondary bacterial and viral infections potentiate this inflammatory reaction being important co-factors for the development of severe disease. One of the hallmarks of malaria syndrome is the paroxysm, which is characterized by high fever associated with peak of parasitemia. In this study we dissected the mechanisms of induction and the importance of the pyrogenic cytokine, IL-1 in the pathogenesis of malaria. Our results demonstrate the critical role of the innate immune receptors named Toll-Like Receptors and inflammasome on induction, processing and release of active form of IL-1 during malaria. Importantly, we provide evidences that bacterial superinfection further potentiates the Plasmodium-induced systemic inflammation, leading to the release of bulk amounts of IL-1 and severe disease. Hence, this study uncovers new checkpoints that could be targeted for preventing systemic inflammation and severe malaria
Compartilhar